Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24
Titel:
Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24
Auteur:
Bar, Jair Ding, Keyue Zhao, Huijun Han, Lei Laurie, Scott A. Seymour, Lesley Addison, Christina L. Shepherd, Frances A. Goss, Glenwood D. Dimitroulakos, Jim Bradbury, Penelope A.